PubRank

S S Pierangeli

Author PubWeight™ 38.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost 2004 2.79
2 Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996 1.65
3 Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation. J Thromb Haemost 2007 1.45
4 Induction of high levels of anticardiolipin antibodies in mice by immunization with beta 2-glycoprotein I does not cause fetal death. Am J Obstet Gynecol 1995 1.41
5 The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996 1.38
6 Real world experience with antiphospholipid antibody tests: how stable are results over time? Ann Rheum Dis 2005 1.15
7 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 2011 1.13
8 Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus 2012 1.05
9 A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Arch Intern Med 1997 0.98
10 Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemost 1995 0.96
11 A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice. Proc Natl Acad Sci U S A 1996 0.96
12 E-Selectin mediates pathogenic effects of antiphospholipid antibodies. J Thromb Haemost 2003 0.94
13 Diagnosis of the antiphospholipid syndrome: a proposal for use of laboratory tests. Lupus 1998 0.94
14 GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro. J Immunol 1999 0.91
15 Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol 1992 0.90
16 Isolated elevation of IgA anti-beta2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients. Lupus 2009 0.88
17 A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice. Lupus 2006 0.88
18 Interactions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1). Clin Exp Immunol 1995 0.88
19 Antiphospholipid antibodies and the antiphospholipid syndrome. Springer Semin Immunopathol 1994 0.86
20 In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies. Ann N Y Acad Sci 2007 0.86
21 Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view. Lupus 2010 0.84
22 Do patients with antiphospholipid syndrome have autoantibodies to beta 2-glycoprotein I? J Lab Clin Med 1993 0.83
23 Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases. J Rheumatol 1999 0.83
24 Revisiting the anticardiolipin test and its standardization. Lupus 2002 0.83
25 Origin of antiphospholipid antibodies. Rheum Dis Clin North Am 2001 0.82
26 More on: fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost 2005 0.82
27 Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis. J Thromb Haemost 2006 0.81
28 Functional effects of anticardiolipin antibodies. Lupus 1996 0.81
29 Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 1995 0.80
30 Mechanisms of pregnancy loss in antiphospholipid syndrome. Clin Obstet Gynecol 2001 0.79
31 Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH. J Thromb Haemost 2014 0.78
32 Inhibition of prothrombin activation by antiphospholipid antibodies and beta 2-glycoprotein 1. Br J Haematol 1994 0.78
33 Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort. Clin Exp Rheumatol 2014 0.77
34 Familial anticardiolipin antibodies and C4 deficiency genotypes that coexist with MHC DQB1 risk factors. J Rheumatol 1995 0.77
35 Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies. Lupus 2004 0.77
36 A re-appraisal of the normal cut-off assignment for anticardiolipin IgM tests. J Thromb Haemost 2006 0.77
37 Thrombogenic properties of antiphospholipid antibodies do not depend on their binding to beta2 glycoprotein 1 (beta2GP1) alone. Lupus 1998 0.77
38 Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review. Scand J Rheumatol Suppl 1998 0.76
39 Anticardiolipin antibodies: importance, controversies, discrepancies; the need for guidelines and calibrators. Clin Exp Rheumatol 2001 0.76
40 Leukocyte-endothelium interaction in arterioles after ischemia and reperfusion. J Surg Res 1999 0.76
41 Origin of antiphospholipid antibodies: induction of aPL by viral peptides. Lupus 1998 0.75
42 Demonstration of antiphospholipid antibody heterogeneity by phospholipid column chromatography and salt gradient elution techniques. Lupus 1995 0.75
43 Comparison of a fluorometric test with the standard ELISA assay for the detection of anticardiolipin antibodies. Clin Exp Rheumatol 1993 0.75
44 Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies. Am J Obstet Gynecol 1997 0.75
45 'Equivocal' antiphospholipid syndrome. J Autoimmun 2000 0.75
46 RBC adhesion to cremaster endothelum in mice with abnormal hemoglobin is increased by topical endotoxin. Ann N Y Acad Sci 1998 0.75
47 New developments in viral peptides and APL induction. J Autoimmun 2000 0.75
48 [Low prevalence of autoimmune antiphospholipid antibodies in hepatic diseases]. Medicina (B Aires) 2000 0.75